CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities:
Net income attributable to common shareholders	$ 57,791	$ 51,662
Noncontrolling interests in subsidiaries' earnings	151	134
Net income before allocation to noncontrolling interests	57,942	51,796
Depreciation and amortization	12,710	14,674
Stock-based compensation expense	5,379	4,007
Defined benefit plans and postretirement expense	943	4,991
Deferred income taxes	8,200	8,544
Cash used for working capital	(98,534)	(103,503)
Defined benefit plans and postretirement contributions	(2,816)	(1,183)
Environmental payments, net of reimbursements	(3,505)	(2,579)
Payments for asbestos-related fees and costs, net of insurance recoveries	(10,493)	(18,235)
Other	9,771	(1,319)
Total provided by operating activities	(20,403)	(42,807)
Investing activities:
Capital expenditures	(5,473)	(7,165)
Proceeds from disposition of capital assets	196	172
Total provided by (used for) investing activities	(5,277)	(6,993)
Equity:
Dividends paid	(16,144)	(15,090)
Stock options exercised - net of shares reacquired	10,389	8,426
Excess tax benefit from stock-based compensation	2,928	2,947
Debt:
Net decrease in short-term debt	0	(318)
Total used for financing activities	(2,827)	(4,035)
Effect of exchange rates on cash and cash equivalents	(10,801)	4,606
Increase (decrease) in cash and cash equivalents	(39,308)	(49,229)
Cash and cash equivalents at beginning of period	423,947	245,089
Cash and cash equivalents at end of period	384,639	195,860
Detail of cash used for working capital:
Accounts receivable	(39,425)	(50,351)
Inventories	(13,026)	(3,318)
Other current assets	(1,096)	(1,112)
Accounts payable	(5,287)	(12,306)
Accrued liabilities	(39,618)	(41,043)
U.S. and foreign taxes on income	(82)	4,627
Total	(98,534)	(103,503)
Supplemental disclosure of cash flow information:
Interest paid	6,013	5,980
Income taxes paid	$ 11,706	$ 4,985